Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients
Status:
Terminated
Trial end date:
2020-04-24
Target enrollment:
Participant gender:
Summary
The goal of this prospective randomized double blinded placebo controlled study is to
investigate if a single dose of ketamine in addition to standard anesthesia will reduce the
risk of delirium in otolaryngeal cancer patients postoperatively. Ketamine's effect on
post-operative pain and opioid use will be measured as well. Electroencephalogram (EEG) will
be utilized during the surgical procedure to evaluate its potential as a possible predictive
device for delirium.